UNSPSC 51434923: Chlorthalidone/reserpine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV400. This VA Drug Class (CV400) classifies this compound as belonging to the group ANTIHYPERTENSIVE COMBINATIONS.

UNSPSC 51434923 Chlorthalidone/reserpine is a Commodity code that represents pharmaceutical products used in emergency medical settings. State and local governments procure advanced life support medications under this code for fire rescue and emergency medical services departments. The City of Tampa's recent solicitation for Advanced Life Support Medications illustrates the actual scope: emergency responders require injectable medications such as Labetalol HCI, Epinephrine, Adenosine, and Diltiazem for field administration during cardiac events and other critical medical emergencies. Issuing bodies are primarily municipal fire departments and emergency medical services units; the source shows direct procurement by city purchasing offices serving fire rescue operations.

The City of Tampa issued an IFB (Invitation for Bid) for Advanced Life Support Medications with a response deadline of April 8, 2026, and an estimated contract value of $40,000.00. The solicitation required sealed bids through the OpenGov eProcurement Portal for specific medication line items with firm pricing including shipping to Tampa, Florida, a one-year initial term with two optional renewals and up to three unilateral 30-day extensions, and a 5 percent bid discount available to Small Local Business Enterprises (SLBEs). Geographic activity is concentrated in Florida based on the available recent-opportunity data. The source contains a single recent opportunity, limiting visibility into broader activity across other states or jurisdictions.